
Anupam Rama
Stock Analyst at J.P. Morgan
(4.88)
# 331
Out of 5,162 analysts
818
Total ratings
48.2%
Success rate
21.1%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENTA Enanta Pharmaceuticals | Reiterated: Buy | $19 → $17 | $7.98 | +113.03% | 4 | Nov 20, 2026 | |
| IDYA IDEAYA Biosciences | Reiterated: Buy | $55 | $26.17 | +110.16% | 41 | Nov 20, 2026 | |
| ETRA Electra Therapeutics | Maintained: Buy | $36 | $8.94 | +302.68% | 1 | Nov 20, 2026 | |
| PROK ProKidney | Maintained: Hold | n/a | $1.06 | - | 7 | Nov 20, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | $128 | $97.90 | +30.75% | 25 | Nov 19, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $26 | $7.70 | +237.66% | 33 | Nov 19, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $20 → $22 | $14.17 | +55.26% | 67 | Nov 19, 2026 | |
| ZLAB Zai Lab | Reiterated: Buy | $36 → $37 | $21.92 | +68.80% | 24 | Nov 19, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $62 → $61 | $27.74 | +119.90% | 18 | Nov 12, 2026 | |
| CTMX CytomX Therapeutics | Reiterated: Buy | $11 → $12 | $2.05 | +485.37% | 15 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.44 | +70.81% | 19 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $44.46 | +57.44% | 6 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $26.75 | +180.37% | 36 | Nov 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.00 | +125.00% | 4 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $51 | $32.43 | +57.26% | 13 | Nov 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.41 | - | 23 | Nov 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $86 | $48.30 | +78.05% | 21 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $156.59 | - | 67 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $107 → $122 | $93.54 | +30.43% | 26 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.44 | +309.84% | 1 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 → $60 | $47.40 | +26.58% | 35 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $157 | $56.31 | +178.81% | 1 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.62 | - | 2 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.15 | - | 32 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $80 → $36 | $17.22 | +109.06% | 32 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $14.22 | +132.07% | 14 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $21 | $19.23 | +9.20% | 35 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $51 → $46 | $12.52 | +267.41% | 2 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $111 | $78.18 | +41.98% | 43 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $40 | $9.13 | +338.12% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.71 | - | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.5884 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $18.52 | +115.98% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $7.72 | n/a | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.52 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $204 → $170 | $147.82 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.35 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | - | n/a | 11 | Nov 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $5 | $6.34 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $64 | $51.46 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $48 | $28.76 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $97.63 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $45 | $124.02 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.61 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $50.37 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $8.87 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.000001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $12.19 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $16.03 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.09 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $41.19 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $58.33 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $195.63 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $4.71 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.18 | n/a | 4 | Jun 15, 2016 |
Enanta Pharmaceuticals
Nov 20, 2026
Reiterated: Buy
Price Target: $19 → $17
Current: $7.98
Upside: +113.03%
IDEAYA Biosciences
Nov 20, 2026
Reiterated: Buy
Price Target: $55
Current: $26.17
Upside: +110.16%
Electra Therapeutics
Nov 20, 2026
Maintained: Buy
Price Target: $36
Current: $8.94
Upside: +302.68%
ProKidney
Nov 20, 2026
Maintained: Hold
Price Target: n/a
Current: $1.06
Upside: -
Kodiak Sciences
Nov 19, 2026
Reiterated: Buy
Price Target: $128
Current: $97.90
Upside: +30.75%
ORIC Pharmaceuticals
Nov 19, 2026
Reiterated: Buy
Price Target: $26
Current: $7.70
Upside: +237.66%
Sarepta Therapeutics
Nov 19, 2026
Reiterated: Hold
Price Target: $20 → $22
Current: $14.17
Upside: +55.26%
Zai Lab
Nov 19, 2026
Reiterated: Buy
Price Target: $36 → $37
Current: $21.92
Upside: +68.80%
Cogent Biosciences
Nov 12, 2026
Reiterated: Buy
Price Target: $62 → $61
Current: $27.74
Upside: +119.90%
CytomX Therapeutics
Nov 12, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $2.05
Upside: +485.37%
Nov 12, 2026
Reiterated: Buy
Price Target: $11
Current: $6.44
Upside: +70.81%
Nov 12, 2026
Reiterated: Buy
Price Target: $70
Current: $44.46
Upside: +57.44%
Nov 12, 2026
Reiterated: Buy
Price Target: $75
Current: $26.75
Upside: +180.37%
Nov 11, 2026
Reiterated: Buy
Price Target: $9
Current: $4.00
Upside: +125.00%
Nov 11, 2026
Rated: Buy
Price Target: $51
Current: $32.43
Upside: +57.26%
Nov 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.41
Upside: -
Nov 6, 2026
Reiterated: Buy
Price Target: $90 → $86
Current: $48.30
Upside: +78.05%
Nov 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $156.59
Upside: -
Oct 30, 2026
Rated: Buy
Price Target: $107 → $122
Current: $93.54
Upside: +30.43%
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.44
Upside: +309.84%
Sep 30, 2026
Rated: Buy
Price Target: $70 → $60
Current: $47.40
Upside: +26.58%
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $157
Current: $56.31
Upside: +178.81%
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.62
Upside: -
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.15
Upside: -
Sep 3, 2026
Downgraded: Hold
Price Target: $80 → $36
Current: $17.22
Upside: +109.06%
Sep 1, 2026
Reiterated: Buy
Price Target: $33
Current: $14.22
Upside: +132.07%
Aug 26, 2026
Rated: Buy
Price Target: $20 → $21
Current: $19.23
Upside: +9.20%
Aug 25, 2026
Rated: Buy
Price Target: $51 → $46
Current: $12.52
Upside: +267.41%
Aug 12, 2026
Rated: Buy
Price Target: $100 → $111
Current: $78.18
Upside: +41.98%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $40
Current: $9.13
Upside: +338.12%
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.71
Upside: -
Mar 24, 2026
Reiterated: Sell
Price Target: n/a
Current: $0.5884
Upside: -
Dec 18, 2025
Reiterated: Buy
Price Target: $40
Current: $18.52
Upside: +115.98%
Nov 18, 2025
Reiterated: Sell
Price Target: $6
Current: $7.72
Upside: n/a
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.52
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $204 → $170
Current: $147.82
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $1.35
Upside: n/a
Nov 13, 2022
Downgraded: Sell
Price Target: n/a
Current: -
Upside: n/a
Aug 15, 2022
Reiterated: Hold
Price Target: $27 → $5
Current: $6.34
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $55 → $64
Current: $51.46
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $50 → $48
Current: $28.76
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $9 → $8
Current: $97.63
Upside: n/a
May 6, 2022
Reiterated: Buy
Price Target: $51 → $45
Current: $124.02
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $3.61
Upside: n/a
Nov 12, 2021
Reiterated: Buy
Price Target: $55
Current: $50.37
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $8.87
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $12.19
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $16.03
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $1.09
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $7 → $6
Current: $41.19
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $58.33
Upside: n/a
Sep 29, 2017
Reiterated: Hold
Price Target: n/a
Current: $195.63
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $4.71
Upside: n/a
Jun 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $11.18
Upside: n/a